A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosisNadia Ashour, Santiago Ropero, J.C. Angulo et al.|The Prostate|2014Cited by 74
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA databaseIngmar Wolff, Sabine Brookman‐May, Ottavio De Cobelli et al.|European Journal of Surgical Oncology|2016Cited by 57
Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1–pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors?Sabine Brookman‐May, Sven Gunia, Matthias May et al.|European Urology|2015Cited by 54
Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation ProfileJ.C. Angulo, Santiago Ropero, Guillermo Andrés et al.|The Journal of Urology|2015Cited by 46
Primary Cisplatin, Methotrexate and Vinblastine Aiming at Bladder Preservation in Invasive Bladder Cancer: Multivariate Analysis on Prognostic FactorsJ.C. Angulo, Nicolás Flores, Manuel Sánchez‐Chapado et al.|The Journal of Urology|1996Cited by 45